1h Free Analyst Time
The publisher has been monitoring the hormonal contraceptives market and it is poised to grow by $ 5.24 bn during 2022-2026, progressing at a CAGR of 5.30% during the forecast period. The report on the hormonal contraceptives market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in unplanned pregnancies and initiatives by government and non-profit organizations.
The hormonal contraceptives market analysis includes the method segment and geographic landscape.
The hormonal contraceptives market is segmented as below:
By Method
- Oral contraceptives
- Implanted contraceptives
- Injected contraceptives
- Intrauterine
- Others
By Geographical Landscape
- North America
- Asia
- Europe
- ROW
This study identifies the increasing adoption of innovative marketing strategies as one of the prime reasons driving the hormonal contraceptives market growth during the next few years.
The report on hormonal contraceptives market covers the following areas:
- Hormonal contraceptives market sizing
- Hormonal contraceptives market forecast
- Hormonal contraceptives market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hormonal contraceptives market vendors that include AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. Also, the hormonal contraceptives market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value chain analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2021 - 2026
Five Forces Analysis
- Five forces summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Method
- Market segments
- Comparison by Method
- Oral contraceptives - Market size and forecast 2021-2026
- Implanted contraceptives - Market size and forecast 2021-2026
- Injected contraceptives - Market size and forecast 2021-2026
- Intrauterine - Market size and forecast 2021-2026
- Others - Market size and forecast 2021-2026
- Market opportunity by Method
Customer landscape
- Overview
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2021-2026
- Asia - Market size and forecast 2021-2026
- Europe - Market size and forecast 2021-2026
- ROW - Market size and forecast 2021-2026
- Key leading countries
- Market opportunity By Geographical Landscape
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Competitive landscape
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- AbbVie Inc.
- Afaxys Pharma LLC
- Bayer AG
- HLL Lifecare Ltd.
- Johnson and Johnson Inc.
- Lupin Ltd.
- Merck and Co. Inc.
- Mylan NV
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2021 - 2026 ($ million)
- Global market: Year-over-year growth 2021 - 2026 (%)
- Five forces analysis 2021 & 2026
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2021
- Method - Market share 2021-2026 (%)
- Comparison by Method
- Oral contraceptives - Market size and forecast 2021-2026 ($ million)
- Oral contraceptives - Year-over-year growth 2021-2026 (%)
- Implanted contraceptives - Market size and forecast 2021-2026 ($ million)
- Implanted contraceptives - Year-over-year growth 2021-2026 (%)
- Injected contraceptives - Market size and forecast 2021-2026 ($ million)
- Injected contraceptives - Year-over-year growth 2021-2026 (%)
- Intrauterine - Market size and forecast 2021-2026 ($ million)
- Intrauterine - Year-over-year growth 2021-2026 (%)
- Others - Market size and forecast 2021-2026 ($ million)
- Others - Year-over-year growth 2021-2026 (%)
- Market opportunity by Method
- Customer landscape
- Market share By Geographical Landscape 2021-2026 (%)
- Geographic comparison
- North America - Market size and forecast 2021-2026 ($ million)
- North America - Year-over-year growth 2021-2026 (%)
- Asia - Market size and forecast 2021-2026 ($ million)
- Asia - Year-over-year growth 2021-2026 (%)
- Europe - Market size and forecast 2021-2026 ($ million)
- Europe - Year-over-year growth 2021-2026 (%)
- ROW - Market size and forecast 2021-2026 ($ million)
- ROW - Year-over-year growth 2021-2026 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Key customers
- AbbVie Inc. - Segment focus
- Afaxys Pharma LLC - Overview
- Afaxys Pharma LLC - Product and service
- Afaxys Pharma LLC - Key offerings
- Afaxys Pharma LLC - Key customers
- Afaxys Pharma LLC - Segment focus
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key offerings
- Bayer AG - Key customers
- Bayer AG - Segment focus
- HLL Lifecare Ltd. - Overview
- HLL Lifecare Ltd. - Product and service
- HLL Lifecare Ltd. - Key offerings
- HLL Lifecare Ltd. - Key customers
- HLL Lifecare Ltd. - Segment focus
- Johnson and Johnson Inc. - Overview
- Johnson and Johnson Inc. - Business segments
- Johnson and Johnson Inc. - Key offerings
- Johnson and Johnson Inc. - Key customers
- Johnson and Johnson Inc. - Segment focus
- Lupin Ltd. - Overview
- Lupin Ltd. - Product and service
- Lupin Ltd. - Key offerings
- Lupin Ltd. - Key customers
- Lupin Ltd. - Segment focus
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Key customers
- Merck and Co. Inc. - Segment focus
- Mylan NV - Overview
- Mylan NV - Business segments
- Mylan NV - Key offerings
- Mylan NV - Key customers
- Mylan NV - Segment focus
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Key customers
- Pfizer Inc. - Segment focus
- Teva Pharmaceutical Industries Ltd. - Overview
- Teva Pharmaceutical Industries Ltd. - Business segments
- Teva Pharmaceutical Industries Ltd. - Key offerings
- Teva Pharmaceutical Industries Ltd. - Key customers
- Teva Pharmaceutical Industries Ltd. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global hormonal contraceptives market: AbbVie Inc., Afaxys Pharma LLC, Bayer AG, HLL Lifecare Ltd., Johnson and Johnson Inc., Lupin Ltd., Merck and Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing adoption of innovative marketing strategies.`
According to the report, one of the major drivers for this market is the increase in unplanned pregnancies.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Afaxys Pharma LLC
- Bayer AG
- HLL Lifecare Ltd.
- Johnson and Johnson Inc.
- Lupin Ltd.
- Merck and Co. Inc.
- Mylan NV
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
